BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen WC, Liu Q, Fu JX, Kang SY. Expression of survivin and its significance in colorectal cancer. World J Gastroenterol 2004; 10(19): 2886-2889 [PMID: 15334693 DOI: 10.3748/wjg.v10.i19.2886]
URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2886.htm
Number Citing Articles
1
Yu Lei, Zhang Geng, Wu Guo-Jun, Wang He, Yuan Jian-Lin. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistanceMolecular and Cellular Biochemistry 2010; 344(1-2): 23 doi: 10.1007/s11010-010-0525-3
2
Marian Adamkov, Desanka Výbohová, Veronika Tupá, Jaroslava Chylíková, Jaroslav Horáček, Marián Benčat. Expression and significance of survivin in colorectal high grade and low grade adenomasActa Histochemica 2015; 117(6): 590 doi: 10.1016/j.acthis.2015.05.006
3
Romain Mathieu, Ilaria Lucca, Mihai D. Vartolomei, Aurélie Mbeutcha, Tobias Klatte, Christian Seitz, Pierre I. Karakiewicz, Harun Fajkovic, Maxine Sun, Yair Lotan, Francesco Montorsi, Alberto Briganti, Morgan Rouprêt, Vitaly Margulis, Michael Rink, Malte Rieken, Lukas Kenner, Martin Susani, Loidl Wolgang, Shahrokh F. Shariat. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi‐institutional studyBJU International 2017; 119(2): 234 doi: 10.1111/bju.13472
4
Ashish Saxena, Mohammad Shoeb, Ravinder Tammali, Kota V. Ramana, Satish K. Srivastava. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db miceCancer Letters 2014; 355(1): 141 doi: 10.1016/j.canlet.2014.09.006
5
Dermot T. McDowell, Fraser M. Smith, John V. Reynolds, Stephen G. Maher, Collette Adida, Paul Crotty, Eoin F. Gaffney, Donal Hollywood, Brian Mehigan, Richard B. Stephens, M. J. Kennedy. Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancerInternational Journal of Colorectal Disease 2009; 24(11): 1261 doi: 10.1007/s00384-009-0755-6
6
Sunetra Ray, Ramasamy Paulmurugan, Manish R Patel, Byeong C Ahn, Lily Wu, Michael Carey, Sanjiv S Gambhir. Noninvasive Imaging of Therapeutic Gene Expression Using a Bidirectional Transcriptional Amplification StrategyMolecular Therapy 2008; 16(11): 1848 doi: 10.1038/mt.2008.180
7
Chao Qin, Qiang Cao, Pu Li, Xiaobing Ju, Meilin Wang, Jiawei Chen, Yilong Wu, Xiaoxin Meng, Jian Zhu, Zhengdong Zhang, Qiang Lu, Changjun Yin, Amanda Ewart Toland. Functional Promoter -31G>C Variant in Survivin Gene Is Associated with Risk and Progression of Renal Cell Cancer in a Chinese PopulationPLoS ONE 2012; 7(1): e28829 doi: 10.1371/journal.pone.0028829
8
TianDuo Wang, Yuanxin Chen, John. A. Ronald. A novel approach for assessment of prostate cancer aggressiveness using survivin-driven tumour-activatable minicirclesGene Therapy 2019; 26(5): 177 doi: 10.1038/s41434-019-0067-6
9
Yongchuan Liao, Hao Zeng, Xiaojie Wang, Ying Huang, Ni Chen, Bo Ge, Li Tang, Qinli Luo. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal glandExperimental Eye Research 2009; 88(1): 4 doi: 10.1016/j.exer.2008.09.015
10
Wencke Reineking, Ida E. Schauerte, Johannes Junginger, Marion Hewicker-Trautwein. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinomaVeterinary Pathology 2022; 59(3): 415 doi: 10.1177/03009858221079666
11
Tatyana Zykova, Feng Zhu, Lei Wang, Haitao Li, Do Young Lim, Ke Yao, Eunmiri Roh, Sang-Pil Yoon, Hong-Gyum Kim, Ki Beom Bae, Weihong Wen, Seung Ho Shin, Janos Nadas, Yan Li, Weiya Ma, Ann M. Bode, Zigang Dong. Targeting PRPK Function Blocks Colon Cancer MetastasisMolecular Cancer Therapeutics 2018; 17(5): 1101 doi: 10.1158/1535-7163.MCT-17-0628
12
M. Grudzinska, K. Lomperta, K. Jakubowska, P. Samocik, K. Jarząbek, L. Kanczuga-Koda, A. Wincewicz, M. Koda. The oncoprotein HBXIP – its functions and roles in oncogenesisProgress in Health Sciences 2018; 8(2): 215 doi: 10.5604/01.3001.0012.8350
13
Bassma Mohamed El Sabaa, Walid Ossman Arafat, Walid Abdel Maksoud. Study of the expression of Survivin in relation to E-Cadherin and their significance in colorectal carcinoma. An immunohistochemical and clinicopathological studyEgyptian Journal of Pathology 2011; 31(2): 37 doi: 10.1097/01.XEJ.0000406590.87075.6c
14
Quan-Xing Ge, Yu-Yuan Li, Yu-Qiang Nie, Wen-Ge Zuo, Yan-Lei Du. Expression of survivin and its four splice variants in colorectal cancer and its clinical significancesMedical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0535-6
15
Alfred King-Yin Lam, Said Saleh, Robert Anthony Smith, Yik-Hong Ho. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activityHuman Pathology 2008; 39(8): 1229 doi: 10.1016/j.humpath.2008.01.001
16
Won Jun Sohn, Jung Won Lee, Dong-Guk Park. Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer CellsJournal of the Korean Society of Coloproctology 2010; 26(4): 246 doi: 10.3393/jksc.2010.26.4.246
17
Jaya Nigam, Abhijit Chandra, Hasan Raza Kazmi, Devendra Parmar, Devendra Singh, Vishal Gupta. Prognostic significance of survivin in resected gallbladder cancerJournal of Surgical Research 2015; 194(1): 57 doi: 10.1016/j.jss.2014.07.054
18
Muhammad Wasif Saif, Antonis Zalonis, Kostas Syrigos. The clinical significance of autoantibodies in gastrointestinal malignancies: an overviewExpert Opinion on Biological Therapy 2007; 7(4): 493 doi: 10.1517/14712598.7.4.493
19
B-C Ahn, J A Ronald, Y I Kim, R Katzenberg, A Singh, R Paulmurugan, S Ray, L V Hofmann, S S Gambhir. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vectorGene Therapy 2011; 18(6): 606 doi: 10.1038/gt.2011.5
20
JingMing Guan, RuiBo Zhao, XueYan Zhang, YanQiu Cheng, YuDong Guo, LiYan Wang, LiNa Mi, Fei Liu, Xiao Ma, BaoJie Li. Chicken Skin Mucosa Surrounding Adult Colorectal Adenomas is a Risk Factor for CarcinogenesisAmerican Journal of Clinical Oncology 2012; 35(6): 527 doi: 10.1097/COC.0b013e31821dedf7
21
Shang-mian Yie, Be Lou, Shang-rong Ye, Mei Cao, Xu He, Ping Li, Kang Hu, Lin Rao, Sheng-min Wu, Hai-bo Xiao, En Gao. Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of RelapseAnnals of Surgical Oncology 2008; 15(11): 3073 doi: 10.1245/s10434-008-0069-x
22
Gyu-Seok Cho, Tae Sung Ahn, Dongjun Jeong, Jae-Jun Kim, Chang-Jin Kim, Hyun-Deuk Cho, Dong-Kook Park, Moo-Jun Baek. Expression of the survivin-2B splice variant related to the progression of colorectal carcinomaJournal of the Korean Surgical Society 2011; 80(6): 404 doi: 10.4174/jkss.2011.80.6.404
23
Christine E. Horak, Julie L. Bronder, Amina Bouadis, Patricia S. Steeg. Apoptosis, Cell Signaling, and Human Diseases2007; : 63 doi: 10.1007/978-1-59745-200-7_3
24
F Li. Role of survivin and its splice variants in tumorigenesisBritish Journal of Cancer 2005; 92(2): 212 doi: 10.1038/sj.bjc.6602340
25
Vergara-Castañeda Haydé, Guevara-González Ramón, Guevara-Olvera Lorenzo, Oomah B. Dave, Reynoso-Camacho Rosalía, Wiersma Paul, Loarca-Piña Guadalupe. Non-digestible fraction of beans (Phaseolus vulgarisL.) modulates signalling pathway genes at an early stage of colon cancer in Sprague–Dawley ratsBritish Journal of Nutrition 2012; 108(S1): S145 doi: 10.1017/S0007114512000785
26
Eman El Zeneini, Sarah Kamel, Mahmoud El-Meteini, Asma Amleh. Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cellsOncology Reports 2017; 37(3): 1896 doi: 10.3892/or.2017.5390
27
Yaoquan Cao, Haibo Tang, Guohui Wang, Pengzhou Li, Zhi Song, Weizheng Li, Xulong Sun, Xiaoxiao Zhong, Qianqian Yu, Shaihong Zhu, Liyong Zhu. Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancerCell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01622-8
28
Nanae Harashima, Keizo Takenaga, Miho Akimoto, Mamoru Harada. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expressionOncotarget 2017; 8(26): 42887 doi: 10.18632/oncotarget.17157
29
Peter C. Konturek, Kazimierz Rembiasz, Grzegorz Burnat, Stanisław J. Konturek, Marcin Tusinela, Władysław Bielanski, Jens Rehfeld, Danuta Karcz, Eckhart Hahn. Effects of Cyclooxygenase-2 Inhibition on Serum and Tumor Gastrins and Expression of Apoptosis-Related Proteins in Colorectal CancerDigestive Diseases and Sciences 2006; 51(4): 779 doi: 10.1007/s10620-006-3206-z
30
EMMANOUIL LIARMAKOPOULOS, GEORGE THEODOROPOULOS, ANNA VAIOPOULOU, SPYROS RIZOS, GERASIMOS ARAVANTINOS, GREGORY KOURAKLIS, NIKOLAOS NIKITEAS, MARIA GAZOULI. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer riskMolecular Medicine Reports 2013; 7(3): 887 doi: 10.3892/mmr.2012.1247
31
John A. Ronald, Hui-Yen Chuang, Anca Dragulescu-Andrasi, Sharon S. Hori, Sanjiv S. Gambhir. Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarkerProceedings of the National Academy of Sciences 2015; 112(10): 3068 doi: 10.1073/pnas.1414156112
32
Woong Na, Se Min Jang, Young Jin Jun, Young Soo Song, Ki‐Seok Jang, Kang Hong Lee, Kyeong Geun Lee, Hong Xiu Han, Seung Sam Paik. Clinicopathologic significance of survivin expression in colorectal adenocarcinomaBasic and Applied Pathology 2009; 2(3): 94 doi: 10.1111/j.1755-9294.2009.01049.x